Nura Bio Funding & Investors
South San Francisco, CA
Nura Bio revolutionizes the treatment of neurological diseases with novel, life-changing neuroprotective medicines. Nura Bio was conceived in 2018 by The Column Group and its scientific founders.
nurabio.comTotal Amount Raised: $141,000,000
Nura Bio Funding Rounds
Series A
$68,000,000
Series A Investors
The Column GroupSamsara BioCapitalEuclidean CapitalSanofi VenturesSeries A
$73,000,000
Series A Investors
The Column GroupEuclidean CapitalSamsara BioCapital
Funding info provided by Diffbot.